Drugs / Sipjeondaebo-tang

Trials 3

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/31 trial
Phase 2/3 NCT03374345 Jan 2018 → Dec 2019 — Gachon University Gil Oriental Medical Hospital Completed No outcome recorded
Phase not applicable2 trials · 1 missed
— NCT02858856 Mar 2017 → Mar 2018 breast carcinoma Kyunghee University Medical Center Unknown No outcome recorded
— NCT02468141 Jul 2015 → Jun 2016 cancer-related condition Kyunghee University Medical Center Completed Missed primary

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 6 sources stand behind the page.

FieldValueCited text
Known as Sipjeondaebo-tang “The purpose of the present study was to examine the feasibility of Sipjeondaebo-tang (Juzen-taiho-to, Shi-Quan-Da-Bu-Tang) for cancer-related anorexia.” PMID 29441116 ↗ Dec 2017
2

NCT02858856 ↗

NCT03374345 ↗

Known as Juzen-taiho-to “Sipjeondaebo-tang (Juzen-taiho-to in Japanese or Shi-Quan-Da-Bu-Tang in Chinese) is a widely used herbal medicine for the treatment of fatigue in Korea, China and Japan.” PMID 29982213 ↗ Jul 2018
1

“The purpose of the present study was to examine the feasibility of Sipjeondaebo-tang (Juzen-taiho-to, Shi-Quan-Da-Bu-Tang) for cancer-related anorexia.” PMID 29441116 ↗ Dec 2017

Known as SDT “Sipjeondaebo-tang (SDT) is widely used in the treatment of various diseases including CHHF by balancing Yin and Yang, restoring the deterioration of physiological function, and...” PMID 30987667 ↗ Apr 2019
Known as Shi-Quan-Da-Bu-Tang “Sipjeondaebo-tang (Juzen-taiho-to in Japanese or Shi-Quan-Da-Bu-Tang in Chinese) is a widely used herbal medicine for the treatment of fatigue in Korea, China and Japan.” PMID 29982213 ↗ Jul 2018
1

“The purpose of the present study was to examine the feasibility of Sipjeondaebo-tang (Juzen-taiho-to, Shi-Quan-Da-Bu-Tang) for cancer-related anorexia.” PMID 29441116 ↗ Dec 2017

Modality Traditional medicine (herbal / TCM) “Sipjeondaebo-tang is one among other popular herbal medicines that are beneficial to management of anorexia in Korea.” PMID 27173813 ↗ May 2016